Announced
ICON BIOSCIENCE INC / EYEPOINT PHARMACEUTICALS INC / Acquisition / Private / £70m
Synopsis
US$100 million acquisition of Icon Bioscience, Inc., a specialty biopharmaceutical company.
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.